Biotechnology · Cell & Gene Therapy
Axent Biosciences: Funding & valuation
Axent Biosciences received $264k in public research grants (NIH, NSF, UKRI) in fiscal 2022.
Data updated Nov 21, 2026 · Back to the company report
Money
Axent Biosciences received $264k in public research grants (NIH, NSF, UKRI) in fiscal 2022.
Research grantsNIH, NSF and UKRI awards
$264kfiscal 2022
$422kfiscal 2021
2awards on record
A Thermoreversible 3D Manufacturing Platform for Scalable Production of Dopaminergic Neurons for Parkinson's Disease Th…
NIH · NINDS · R43 · Jun 2022
$264k
A Thermoreversible 3D Manufacturing Platform for Scalable Production of Dopaminergic Neurons for Parkinson's Disease Th…
NIH · NINDS · R43 · Jul 2021
$422k
People cost
Axent Biosciences filed a median H-1B wage of $117k in 2025.
Median H-1B wage by role, 2025scale to $117k
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
